Funded Tech Companies
180 Life Sciences
180 Life Sciences, based in Palo Alto, raised money from Omicron Media, Electric Capital and GSR.
Company Overview
Company Name
180 Life Sciences
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
3000 El Camino Real, Building 4 200
Palo Alto, CA 94306
USA
Palo Alto, CA 94306
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
The company is a clinical stage biotechnology company headquartered in Palo Alto, California, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy. We have three different product development families that are focused on different diseases or medical conditions, and that target different factors, molecules or proteins, as follows: Anti-TNF (clinical; focusing on fibrosis and anti-tumor necrosis factor) SCAs (focusing on drugs which are synthetic cannabidiol or cannabigerol analogs), and Anti-TNF (preclinical; orally bioavailable).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/29/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Blair Jordan
Company Investors
- Omicron Media
- Electric Capital
- GSR
- Polychain Capital
- Private Investors (Danny Ryan)
- Private Investors (Grant Hummer)
- Private Investors (Konstantin Lomashuk)
- Private Investors (Mike Silagadze)
- Private Investors (Robert Leshner)
- Private Investors (Sam Kazemanian)
- Private Investors (Sreeram Kannan)
- Private Investors (Tarun Chitra)
- Private Investors (Vivek Raman)
Browse more funded tech companies:
180 Health Partners | 180° Seguros
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs